Terms: = Endocrine gland cancer AND CEACAM5, CEA
2052 results:
1. A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma.
Tang H; Miao X; Yu C; Chai C; Su Y; Li L; Yi J; Ye Z; Miao L; Wang Z; Zhang H; Xu H; Zhou W
Sci Rep; 2024 Apr; 14(1):9259. PubMed ID: 38649719
[TBL] [Abstract] [Full Text] [Related]
2. Performance of Intracystic Glucose Measurement for the Characterization of Pancreatic Cystic Lesions.
Ribeiro T; Lopes S; Moutinho-Ribeiro P; Macedo G; Vilas-Boas F
J Gastrointestin Liver Dis; 2024 Mar; 33(1):74-78. PubMed ID: 38554431
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of the Cutoff Point and Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio in Predicting Ovarian cancer Compared to Pathological Findings.
Hosseini MS; Amiri F; Rezapour M; Ashraf Ganjoie T; Farzaneh F; Arab M; Talayeh M; Beheshti Rooy R; Hadi F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):971-976. PubMed ID: 38546079
[TBL] [Abstract] [Full Text] [Related]
4. Neutrophil Gelatinase-Associated Lipocalin for the Differentiation of Mucinous Pancreatic Cystic Lesions.
Olar MP; Iacobescu M; Bolboacă SD; Pojoga C; Moșteanu O; Seicean R; Rusu I; Banc O; Iuga CA; Seicean A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542201
[TBL] [Abstract] [Full Text] [Related]
5. Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
[TBL] [Abstract] [Full Text] [Related]
6. Mucin-producing tumors of the ovary--preoperative differentiation between metastatic ovarian mucinous carcinoma and primary mucinous malignant tumors.
Cai SQ; Wu MR; Ma XL; Lu JJ; Qiang JW; Guan YY; Zeng MS; Zhou JJ
J Ovarian Res; 2024 Mar; 17(1):59. PubMed ID: 38481236
[TBL] [Abstract] [Full Text] [Related]
7. Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic cancer: A Multicenter Cohort Study.
Huang J; Gao G; Ge Y; Liu J; Cui H; Zheng R; Wang J; Wang S; Go VL; Hu S; Liu Y; Yang M; Sun Y; Shang D; Tian Y; Zhang Z; Xiang Z; Wang H; Guo J; Xiao GG
Dig Dis Sci; 2024 Apr; 69(4):1263-1273. PubMed ID: 38451429
[TBL] [Abstract] [Full Text] [Related]
8. [Ultrasonographic features of thyroid carcinoma of different sizes: comparison between medullary thyroid carcinomas and papillary thyroid carcinomas].
Zhang D; Yang F; Wang Y; Mu JL; Wei XQ; Wei X
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):133-139. PubMed ID: 38418187
[No Abstract] [Full Text] [Related]
9. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
[TBL] [Abstract] [Full Text] [Related]
10. [A Case of Sigmoid Colon cancer with Simultaneous Solitary Adrenal Metastasis Refractory to Preoperative Diagnosis].
Saito T; Shibutani M; Fukuoka T; Kasashima H; Kitayama K; Tamura T; Toyokawa T; Ree S; Tanaka H; Kato M; Hirayama Y; Matsue T; Masuda K; Uchida J; Maeda K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1557-1559. PubMed ID: 38303340
[TBL] [Abstract] [Full Text] [Related]
11. New ceaCAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.
Jancewicz I; Śmiech M; Winiarska M; Zagozdzon R; Wisniewski P
Cancer Immunol Immunother; 2024 Jan; 73(2):30. PubMed ID: 38279989
[TBL] [Abstract] [Full Text] [Related]
12. An audit of medullary thyroid carcinoma from a tertiary care hospital in northwest India.
Chakraborty AM; Rai A; Pal R; Mukherjee S; Dahiya D; Kumar R; Saikia UN; Panda NK; Bhadada SK; Dutta P
Front Endocrinol (Lausanne); 2023; 14():1226348. PubMed ID: 38260132
[TBL] [Abstract] [Full Text] [Related]
13. CA19-9 and cea biosensors in pancreatic cancer.
Ahmadipour M; Bhattacharya A; Sarafbidabad M; Syuhada Sazali E; Krishna Ghoshal S; Satgunam M; Singh R; Rezaei Ardani M; Missaoui N; Kahri H; Pal U; Ling Pang A
Clin Chim Acta; 2024 Feb; 554():117788. PubMed ID: 38246211
[TBL] [Abstract] [Full Text] [Related]
14. The emerging roles of ceaCAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
15. Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review.
Kwan MC; Pitman MB; Fernandez-Del Castillo C; Zhang ML
Gut; 2024 Mar; 73(4):629-638. PubMed ID: 38195219
[TBL] [Abstract] [Full Text] [Related]
16. Serum cea as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study.
Doppenberg D; Stoop TF; van Dieren S; Katz MHG; Janssen QP; Nasar N; Prakash LR; Theijse RT; Tzeng CD; Wei AC; Zureikat AH; Groot Koerkamp B; Besselink MG;
Ann Surg Oncol; 2024 Mar; 31(3):1919-1932. PubMed ID: 38170408
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Effect of Preoperative Inflammatory Markers on Morbidity and Overall Survival in Pancreatic Adenocarsinoma.
Çaparlar MA; Durhan A; Süleymanov M; Binarbaşı C; Koşmaz K
Niger J Clin Pract; 2023 Dec; 26(12):1902-1909. PubMed ID: 38158359
[TBL] [Abstract] [Full Text] [Related]
18. Development and characterization of NILK-2301, a novel ceacam5xCD3 κλ bispecific antibody for immunotherapy of ceacam5-expressing cancers.
Seckinger A; Majocchi S; Moine V; Nouveau L; Ngoc H; Daubeuf B; Ravn U; Pleche N; Calloud S; Broyer L; Cons L; Lesnier A; Chatel L; Papaioannou A; Salgado-Pires S; Krämer S; Gockel I; Lordick F; Masternak K; Poitevin Y; Magistrelli G; Malinge P; Shang L; Kallendrusch S; Strein K; Hose D
J Hematol Oncol; 2023 Dec; 16(1):117. PubMed ID: 38087365
[TBL] [Abstract] [Full Text] [Related]
19. Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions.
Rossi G; Petrone MC; Tacelli M; Zaccari P; Crippa S; Belfiori G; Aleotti F; Locatelli M; Piemonti L; Doglioni C; Falconi M; Capurso G; Arcidiacono PG
Dig Liver Dis; 2024 May; 56(5):836-840. PubMed ID: 38008697
[TBL] [Abstract] [Full Text] [Related]
20. Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study.
Hau SO; Svensson M; Petersson A; Eberhard J; Jirström K
BMC Cancer; 2023 Nov; 23(1):1074. PubMed ID: 37936126
[TBL] [Abstract] [Full Text] [Related]
[Next]